Landon Investments, the venture capital arm of Spanish family office Grupo Corporativo Landon, has completed a EUR 28m capital increase.
Existing investors including Institut Català de Finances also take part in the financing
Biotech company initially raised €12m in December 2018
Amount includes the capital raised by Eurazeo Growth III, which has now collected more than €500m
Allan Marchington, who will become head of ICG life sciences, says the team has a strong pipeline